Literature DB >> 7030942

Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.

M G Deo, C V Bapat, R G Chullawalla, W S Bhatki.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 7030942

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN： 0971-5916            Impact factor:   2.375


× No keyword cloud information.
  5 in total

1.  An immunodominant 30-kDa antigen of a candidate anti-leprosy vaccine, Mycobacterium w, shares T and B cell determinants with M. leprae and M. tuberculosis.

Authors:  A Yadava; R Mukherjee
Journal:  Med Microbiol Immunol       Date:  1993-11       Impact factor: 3.402

Review 2.  Pathology and pathogenesis of predilective sites of nerve damage in leprous neuritis. Nerves in the arm and the face.

Authors:  D K Dastur
Journal:  Neurosurg Rev       Date:  1983       Impact factor: 3.042

Review 3.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

4.  Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequence.

Authors:  C M Grosskinsky; W R Jacobs; J E Clark-Curtiss; B R Bloom
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

5.  Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.

Authors:  I Nath; M Sathish; T Jayaraman; L K Bhutani; A K Sharma
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.